Valencia Nutrition [VALENCIA] vs Dishman Carbogen [DCAL] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Valencia Nutrition Ltd. wins in 6 metrics, Dishman Carbogen Amcis Ltd. wins in 12 metrics, with 0 ties. Dishman Carbogen Amcis Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Valencia Nutrition Ltd. | Dishman Carbogen Amcis Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 38.74 | 22.30 | Dishman Carbogen Amcis Ltd. |
| Price-to-Book Ratio | 3.56 | 0.42 | Dishman Carbogen Amcis Ltd. |
| Debt-to-Equity Ratio | 47.66 | 40.20 | Dishman Carbogen Amcis Ltd. |
| PEG Ratio | N/A | -0.16 | N/A |
| EV/EBITDA | 47.50 | 9.62 | Dishman Carbogen Amcis Ltd. |
| Profit Margin (TTM) | 27.73% | 4.25% | Valencia Nutrition Ltd. |
| Operating Margin (TTM) | 19.80% | 3.99% | Valencia Nutrition Ltd. |
| EBITDA Margin (TTM) | 19.80% | 3.99% | Valencia Nutrition Ltd. |
| Return on Equity | 10.80% | 0.06% | Valencia Nutrition Ltd. |
| Return on Assets (TTM) | 4.41% | 0.03% | Valencia Nutrition Ltd. |
| Free Cash Flow (TTM) | $-198.09M | $1.58B | Dishman Carbogen Amcis Ltd. |
| 1-Year Return | 25.56% | -26.89% | Valencia Nutrition Ltd. |
| Price-to-Sales Ratio (TTM) | 12.67 | 0.95 | Dishman Carbogen Amcis Ltd. |
| Enterprise Value | $1.50B | $46.55B | Dishman Carbogen Amcis Ltd. |
| EV/Revenue Ratio | 14.13 | 1.66 | Dishman Carbogen Amcis Ltd. |
| Gross Profit Margin (TTM) | -453.63% | 80.34% | Dishman Carbogen Amcis Ltd. |
| Revenue per Share (TTM) | $6 | $179 | Dishman Carbogen Amcis Ltd. |
| Earnings per Share (Diluted) | $2.02 | $7.58 | Dishman Carbogen Amcis Ltd. |
| Beta (Stock Volatility) | 0.51 | 0.40 | Dishman Carbogen Amcis Ltd. |
Valencia Nutrition Ltd. vs Dishman Carbogen Amcis Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Valencia Nutrition Ltd. | -7.01% | -12.11% | -2.27% | 1.52% | -10.87% | -9.78% |
| Dishman Carbogen Amcis Ltd. | -1.99% | -1.29% | 4.71% | 18.97% | -17.56% | -23.92% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Valencia Nutrition Ltd. | 25.56% | 46.69% | 302.48% | 225.81% | 225.81% | 225.81% |
| Dishman Carbogen Amcis Ltd. | -26.89% | 58.94% | -7.70% | 27.01% | 314.26% | 123.54% |
Performance & Financial Health Analysis: Valencia Nutrition Ltd. vs Dishman Carbogen Amcis Ltd.
| Metric | VALENCIA | DCAL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.09B | ₹26.50B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 3,750 | 337,264 |
| 90 Day Avg. Volume | 4,200 | 517,904 |
| Last Close | ₹63.28 | ₹195.13 |
| 52 Week Range | ₹47.00 - ₹97.10 | ₹128.50 - ₹321.95 |
| % from 52W High | -34.83% | -39.39% |
| All-Time High | ₹97.10 (Nov 07, 2025) | ₹396.40 (Jan 22, 2018) |
| % from All-Time High | -34.83% | -50.77% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 1.39% | 0.06% |
| Quarterly Earnings Growth | N/A | -0.09% |
| Financial Health | ||
| Profit Margin (TTM) | 0.28% | 0.04% |
| Operating Margin (TTM) | 0.20% | 0.04% |
| Return on Equity (TTM) | 0.11% | 0.00% |
| Debt to Equity (MRQ) | 47.66 | 40.20 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹21.98 | ₹405.67 |
| Cash per Share (MRQ) | ₹0.16 | ₹40.41 |
| Operating Cash Flow (TTM) | ₹-148,430,000 | ₹-199,700,000 |
| Levered Free Cash Flow (TTM) | ₹-326,869,504 | ₹32.40M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Valencia Nutrition Ltd. vs Dishman Carbogen Amcis Ltd.
| Metric | VALENCIA (Apr 24, 2026) | DCAL (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 38.74 | 22.30 |
| Forward P/E | N/A | 13.52 |
| PEG Ratio | N/A | -0.16 |
| Price to Sales (TTM) | 12.67 | 0.95 |
| Price to Book (MRQ) | 3.56 | 0.42 |
| Market Capitalization | ||
| Market Capitalization | ₹1.09B | ₹26.50B |
| Enterprise Value | ₹1.50B | ₹46.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 14.13 | 1.66 |
| Enterprise to EBITDA | 47.50 | 9.62 |
| Risk & Other Metrics | ||
| Beta | 0.51 | 0.40 |
| Book Value per Share (MRQ) | ₹21.98 | ₹405.67 |
Financial Statements Comparison: Valencia Nutrition Ltd. vs Dishman Carbogen Amcis Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | VALENCIA (2025) | DCAL (2025) |
|---|---|---|
| Revenue/Sales | 84.71M | 26.42B |
| Cost of Goods Sold | 44.84M | 5.26B |
| COGS % of Revenue | 52.9% | 19.9% |
| Gross Profit | 39.87M | 21.16B |
| Gross Margin | 47.1% | 80.1% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 6.46M | 1.46B |
| Operating Margin | 7.6% | 5.5% |
| EBITDA | 13.36M | 4.83B |
| EBITDA Margin | 15.8% | 18.3% |
| Pre-Tax Income | 10.74M | 193.10M |
| Pre-Tax Income % of Revenue | 12.7% | 0.7% |
| Income Tax | 0 | 160.70M |
| Income Tax % of Revenue | 0.0% | 0.6% |
| Net Income (Profit) | 10.74M | 32.40M |
| Profit Margin | 12.7% | 0.1% |
Balance Sheet & Liquidity Metrics
| Metric | VALENCIA (2025) | DCAL (2025) |
|---|---|---|
| Cash & Equivalents | 1.41M | 2.86B |
| Total Current Assets | 272.88M | 22.00B |
| Total Current Assets % of Revenue | 322.1% | 83.3% |
| Total Current Liabilities | 3.49M | 19.25B |
| Total Current Liabilities % of Revenue | 4.1% | 72.9% |
| Long-Term Debt | 14.87M | 13.90B |
| Long-Term Debt % of Revenue | 17.6% | 52.6% |
| Total Shareholders Equity | 365.81M | 58.32B |
| Retained Earnings | -179.82M | 2.13B |
| Retained Earnings % of Revenue | -212.3% | 8.1% |
| Property, Plant & Equipment | 3.27M | 10.27B |
Cash Flow Statement Comparison
| Metric | VALENCIA (2025) | DCAL (2025) |
|---|---|---|
| Operating Cash Flow | -158.47M | -199.70M |
| Operating Cash Flow % of Revenue | -187.1% | -0.8% |
| Capital Expenditures | -40.80M | -2.15B |
| Free Cash Flow | -198.09M | 1.58B |
| FCF Margin | -233.8% | 6.0% |
| Debt Repayment | -38.53M | -1.10B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VALENCIA | DCAL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 16.98M | 156.78M |
| Float Shares | 2.49M | 54.95M |
| % Held by Insiders | 81.67% | 69.30% |
| % Held by Institutions | 0.00% | 2.41% |
| % Held by Public | 18.33% | 28.29% |
Dividend Analysis & Yield Comparison: Valencia Nutrition Ltd. vs Dishman Carbogen Amcis Ltd.
| Metric | VALENCIA | DCAL |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | ₹0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | ₹0.00 |
| Ex-Dividend Date | N/A | N/A |